Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy

References

• Clark RA. Skin-resident T cells: the ups and downs of on site immunity. J Invest Dermatol 2010; 130:362-70; PMID:19675575; http://dx.doi.org/10.1038/jid.2009.247
   PubMed Web of Science ®Google Scholar
• Bogle MA, Riddle CC, Triana EM, Jones D, Duvic M. Primary cutaneous B-cell lymphoma. J Am Acad Dermatol 2005; 53:479-84; PMID:16112357; http://dx.doi.org/10.1016/j.jaad.2005.04.043
   PubMed Web of Science ®Google Scholar
• Suzuki R. Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma. Seminars Hematol 2014; 51:42-51; PMID:24468315; http://dx.doi.org/10.1053/j.seminhematol.2013.11.007
   PubMed Web of Science ®Google Scholar
• Tsukasaki K, Tobinai K. Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research. Clin Cancer Res 2014; 20:5217-25; PMID:25320371; http://dx.doi.org/10.1158/1078-0432.CCR-14-0572
   PubMed Web of Science ®Google Scholar
• Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, Zackheim H, Duvic M, Estrach T, Lamberg S et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110:1713-22; PMID:17540844; http://dx.doi.org/10.1182/blood-2007-03-055749
   PubMed Web of Science ®Google Scholar
• Korgavkar K, Xiong M, Weinstock M. Changing incidence trends of cutaneous T-cell lymphoma. JAMA Dermatol 2013; 149:1295-9; PMID:24005876; http://dx.doi.org/10.1001/jamadermatol.2013.5526
   PubMed Web of Science ®Google Scholar
• Scarisbrick JJ, Prince HM, Vermeer MH, Quaglino P, Horwitz S, Porcu P, Stadler R, Wood GS, Beylot-Barry M, Pham-Ledard A et al. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sezary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model. J Clin Oncol 2015; 33:3766-73; PMID:26438120; http://dx.doi.org/10.1200/JCO.2015.61.7142
   PubMed Web of Science ®Google Scholar
• Litvinov IV, Tetzlaff MT, Rahme E, Habel Y, Risser DR, Gangar P, Jennings MA, Pehr K, Prieto VG, Sasseville D et al. Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries. Cancer 2015; 121:1993-2003; PMID:25728286; http://dx.doi.org/10.1002/cncr.29301
   PubMed Web of Science ®Google Scholar
• Mirvish JJ, Pomerantz RG, Falo LD, Jr, Geskin LJ. Role of infectious agents in cutaneous T-cell lymphoma: facts and controversies. Clinics Dermatol 2013; 31:423-31; PMID:23806159; http://dx.doi.org/10.1016/j.clindermatol.2013.01.009
   PubMed Web of Science ®Google Scholar
• Litvinov IV, Tetzlaff MT, Rahme E, Jennings MA, Risser DR, Gangar P, Netchiporouk E, Moreau L, Prieto VG, Sasseville D et al. Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries. Cancer Med 2015; 4:1440-7; PMID:26136403; http://dx.doi.org/10.1002/cam4.472
   PubMed Web of Science ®Google Scholar
• Moreau JF, Buchanich JM, Geskin JZ, Akilov OE, Geskin LJ. Non-random geographic distribution of patients with cutaneous T-cell lymphoma in the Greater Pittsburgh Area. Dermatol Online J 2014; 20:13030/qt4nw7592w; PMID:25046454
   PubMedGoogle Scholar
• Gip L, Nilsson E. [Clustering of mycosis fungoides in the County of Vasternorrland]. Lakartidningen 1977; 74:1174-6; PMID:850446
   PubMedGoogle Scholar
• Jackow CM, Cather JC, Hearne V, Asano AT, Musser JM, Duvic M. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V β gene expansion. Blood 1997; 89:32-40; PMID:8978274
   PubMed Web of Science ®Google Scholar
• Abrams JT, Balin BJ, Vonderheid EC. Association between Sezary T cell-activating factor, Chlamydia pneumoniae, and cutaneous T cell lymphoma. Ann N Y Acad Sci 2001; 941:69-85; PMID:11594584; http://dx.doi.org/10.1111/j.1749-6632.2001.tb03712.x
   PubMed Web of Science ®Google Scholar
• Gessain A, Cassar O. Epidemiological Aspects and World Distribution of HTLV-1 Infection. Frontiers Microbiol 2012; 3:388; PMID:23162541; http://dx.doi.org/10.3389/fmicb.2012.00388
   PubMed Web of Science ®Google Scholar
• Zucker-Franklin D, Pancake BA. The role of human T-cell lymphotropic viruses (HTLV-I and II) in cutaneous T-cell lymphomas. Seminars Dermatol 1994; 13:160-5; PMID:7986683
   PubMedGoogle Scholar
• Detmar M, Pauli G, Anagnostopoulos I, Wunderlich U, Herbst H, Garbe C, Stein H, Orfanos CE. A case of classical mycosis fungoides associated with human T-cell lymphotropic virus type I. Br J Dermatol 1991; 124:198-202; PMID:2004007; http://dx.doi.org/10.1111/j.1365-2133.1991.tb00434.x
   PubMed Web of Science ®Google Scholar
• Pawlaczyk M, Filas V, Sobieska M, Gozdzicka-Jozefiak A, Wiktorowicz K, Breborowicz J. No evidence of HTLV-I infection in patients with mycosis fungoides and Sezary syndrome. Neoplasma 2005; 52:52-5; PMID:15739027
   PubMed Web of Science ®Google Scholar
• Grossman D, Rapini RP, Osborne B, Duvic M. Emergence of leprosy in a patient with mycosis fungoides. J Am Acad Dermatol 1994; 30:313-5; PMID:8294589; http://dx.doi.org/10.1016/S0190-9622(94)70030-3
   PubMed Web of Science ®Google Scholar
• Levy ML, Rosen T, Tschen JA, McGavran MH, Kalter DC. Hansen's disease following lymphoma. J Am Acad Dermatol 1986; 15:204-8; PMID:3745525; http://dx.doi.org/10.1016/S0190-9622(86)70157-6
   PubMed Web of Science ®Google Scholar
• Siriphukpong S, Pattanaprichakul P, Sitthinamsuwan P, Karoopongse E. Granulomatous mycosis fungoides with large cell transformation misdiagnosed as leprosy. J Medical Association Thailand = Chotmaihet Thangphaet 2010; 93:1321-6; PMID:21114213
   PubMedGoogle Scholar
• Talpur R, Bassett R, Duvic M. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sezary syndrome. Br J Dermatol 2008; 159:105-12; PMID:18489588; http://dx.doi.org/10.1111/j.1365-2133.2008.08612.x
   PubMed Web of Science ®Google Scholar
• Lee M, Van Bever H. The role of antiseptic agents in atopic dermatitis. Asia Pacific Allergy 2014; 4:230-40; PMID:25379483; http://dx.doi.org/10.5415/apallergy.2014.4.4.230
   PubMedGoogle Scholar
• Powers CE, McShane DB, Gilligan PH, Burkhart CN, Morrell DS. Microbiome and pediatric atopic dermatitis. J Dermatol 2015; 42(12):1137-42; PMID:26388516; http://dx.doi.org/10.1111/1346-8138.13072
   PubMed Web of Science ®Google Scholar
• Litvinov IV, Cordeiro B, Fredholm S, Odum N, Zargham H, Huang Y, Zhou Y, Pehr K, Kupper TS, Woetmann A et al. Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines. Cell Cycle 2014; 13:2975-82; PMID:25486484; http://dx.doi.org/10.4161/15384101.2014.947759
   PubMed Web of Science ®Google Scholar
• Netchiporouk E, Litvinov IV, Moreau L, Gilbert M, Sasseville D, Duvic M. Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression. Cell Cycle 2014; 13:3331-5; PMID:25485578; http://dx.doi.org/10.4161/15384101.2014.965061
   PubMed Web of Science ®Google Scholar
• Tokura Y, Yagi H, Ohshima A, Kurokawa S, Wakita H, Yokote R, Shirahama S, Furukawa F, Takigawa M. Cutaneous colonization with staphylococci influences the disease activity of Sezary syndrome: a potential role for bacterial superantigens. Br J Dermatol 1995; 133:6-12; PMID:7669641; http://dx.doi.org/10.1111/j.1365-2133.1995.tb02485.x
   PubMed Web of Science ®Google Scholar
• Andreas WO, Thorbjørn K, Lise ML, Ivan VL, Simon F, David LP, Claudia N, Robert G, Nigel PM, Denis S et al. Staphylococcus aureus enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma. Blood. 2016 Mar 10; 127:1287-96; PMID:26738536; http://dx.doi.org/10.1182/blood-2015-08-662353
   Web of Science ®Google Scholar
• Krejsgaard T, Litvinov IV, Wang Y, Xia L, Willerslev-Olsen A, Koralov SB, Kopp KL, Bonefeld CM, Wasik MA, Geisler C et al. Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma. Blood 2013; 122:943-50; PMID:23801634; http://dx.doi.org/10.1182/blood-2013-01-480889
   PubMed Web of Science ®Google Scholar
• Litvinov IV, Pehr K, Sasseville D. Connecting the dots in cutaneous T cell lymphoma (CTCL): STAT5 regulates malignant T cell proliferation via miR-155. Cell cycle 2013; 12:2172-3; PMID:23803726; http://dx.doi.org/10.4161/cc.25550
   PubMed Web of Science ®Google Scholar
• Sibbesen NA, Kopp KL, Litvinov IV, Jonson L, Willerslev-Olsen A, Fredholm S, Petersen DL, Nastasi C, Krejsgaard T, Lindahl LM et al. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma. Oncotarget 2015; 6:20555-69; PMID:26244872; http://dx.doi.org/10.18632/oncotarget.4111
   PubMed Web of Science ®Google Scholar
• Willerslev-Olsen A, Litvinov IV, Fredholm SM, Petersen DL, Sibbesen NA, Gniadecki R, Zhang Q, Bonefeld CM, Wasik MA, Geisler C et al. IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF). Cell Cycle 2014; 13:1306-12; PMID:24621498; http://dx.doi.org/10.4161/cc.28256
   PubMed Web of Science ®Google Scholar
• Litvinov IV, Netchiporouk E, Cordeiro B, Dore MA, Moreau L, Pehr K, Gilbert M, Zhou Y, Sasseville D, Kupper TS. The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL). Clin Cancer Res 2015; 21:2820-9; PMID:25779945; http://dx.doi.org/10.1158/1078-0432.CCR-14-3322
   PubMed Web of Science ®Google Scholar
• Humphreys H. Staphylococcus aureus: the enduring pathogen in surgery. Surg 2012; 10:357-60; PMID:23079115; http://dx.doi.org/10.1016/j.surge.2012.05.003
   PubMed Web of Science ®Google Scholar
• Tokura Y, Heald PW, Yan SL, Edelson RL. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins. J Invest Dermatol 1992; 98:33-7; PMID:1728639; http://dx.doi.org/10.1111/1523-1747.ep12494184
   PubMed Web of Science ®Google Scholar
• Talpur R, Cox KM, Hu M, Geddes ER, Parker MK, Yang BY, Armstrong PA, Liu P, Duvic M. Vitamin D deficiency in mycosis fungoides and Sezary syndrome patients is similar to other cancer patients. Clin Lymphoma Myeloma Leukemia 2014; 14:518-24; PMID:25442486; http://dx.doi.org/10.1016/j.clml.2014.06.023
   PubMed Web of Science ®Google Scholar
• Mitchell DM, Henao MP, Finkelstein JS, Burnett-Bowie SA. Prevalence and predictors of vitamin D deficiency in healthy adults. Endocrine Practice 2012; 18:914-23; PMID:22982792; http://dx.doi.org/10.4158/EP12072.OR
   PubMed Web of Science ®Google Scholar
• Kricker A, Armstrong BK, Hughes AM, Goumas C, Smedby KE, Zheng T, Spinelli JJ, De Sanjosé S, Hartge P, Melbye M et al. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer J Int Du Cancer 2008; 122:144-54; PMID:17708556; http://dx.doi.org/10.1002/ijc.23003
   PubMed Web of Science ®Google Scholar
• Murphy G, Reich K. In touch with psoriasis: topical treatments and current guidelines. J Eur Acad Dermatol Venereol 2011; 25 Suppl 4:3-8; PMID:21507077; http://dx.doi.org/10.1111/j.1468-3083.2011.04059.x
   PubMed Web of Science ®Google Scholar
• Guo C, Gombart AF. The antibiotic effects of vitamin D. Endocrine Metab Immune Disorders Drug Targets 2014; 14:255-66; PMID:25008764; http://dx.doi.org/10.2174/1871530314666140709085159
   PubMed Web of Science ®Google Scholar
• Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-3; PMID:16497887; http://dx.doi.org/10.1126/science.1123933
   PubMed Web of Science ®Google Scholar
• Jahan-Tigh RR, Huen AO, Lee GL, Pozadzides JV, Liu P, Duvic M. Hydrochlorothiazide and cutaneous T cell lymphoma: prospective analysis and case series. Cancer 2013; 119:825-31; PMID:22952039; http://dx.doi.org/10.1002/cncr.27740
   PubMed Web of Science ®Google Scholar
• Magro CM, Crowson AN. Drugs with antihistaminic properties as a cause of atypical cutaneous lymphoid hyperplasia. J Am Acad Dermatol 1995; 32:419-28; PMID:7868710; http://dx.doi.org/10.1016/0190-9622(95)90063-2
   PubMed Web of Science ®Google Scholar
• Rijlaarsdam U, Scheffer E, Meijer CJ, Kruyswijk MR, Willemze R. Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy. J Am Acad Dermatol 1991; 24:216-20; PMID:1826111; http://dx.doi.org/10.1016/0190-9622(91)70029-2
   PubMed Web of Science ®Google Scholar
• Peck JR, Frank MP, Peck LR. Was treatment the trigger? Mycosis fungoides. Am J Med 2013; 126:1048-9; PMID:24083643; http://dx.doi.org/10.1016/j.amjmed.2013.08.007
   PubMed Web of Science ®Google Scholar